NFE2L2 and myeloid sarcoma: A still unresolved issue in overcoming OS-induced lesions in MS is the failure to activate the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, which basically plays a critical role in preventing mitochondrial failure, OS, neuroinflammation, and degeneration [6].